trending Market Intelligence /marketintelligence/en/news-insights/trending/kvthgyixaj1xmzg1haul_w2 content esgSubNav
In This List

Imagion Biosystems to move US operations to San Diego

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Imagion Biosystems to move US operations to San Diego

Melbourne, Australia's Imagion Biosystems Inc. said it will relocate its U.S. business to San Diego.

Imagion, which develops cancer detection technology, said the move to San Diego, a biotechnology hub, will help accelerate the company's development and open collaboration opportunities.

The company expects to be fully operational in its new location by the second quarter of 2018. The company said costs related to the relocation are not material and overall effect on spending is expected to be neutral.